Investigates molecular and cellular mechanisms of tauopathies, including tau expression, splicing, release, aggregation, spreading, and regional vulnerability. Uses conventional cell systems and human iPSC-derived neuronal models carrying Alzheimer's disease and frontotemporal-dementia risk variants to identify therapeutic pathways.